GeneDx Holdings Corp. (WGS) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

GeneDx Holdings Corp. (WGS) closed at USD 68.61 on 2026-10-14, a change of -50.1 % over the past year, with a market capitalization of USD 2.09B.

GeneDx Holdings Corp. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

GeneDx Holdings Corp. key figures

Previous close

USD 68.61 (2026-10-14)

1-year change

-50.1 %

Market cap

USD 2.09B

Enterprise value

USD 2.13B

P/E ratio (trailing)

-17.87

P/E ratio (forward)

58.59

EPS (trailing)

-3.93

EPS (forward)

1.20

PEG ratio

n/a

Price to book

8.57

Revenue growth

11.4 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

7.71

Employees

1,300

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About GeneDx Holdings Corp.

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for GeneDx Holdings Corp. and compare it with other stocks.